ESMO Advanced Course on Biomarkers for Precision Medicine

Learning objectives

• An increasing number of therapeutics that require biomarkers testing are available for clinical use or are in advanced phase of clinical development
• Different technologies can be used for biomarker testing depending on the nature of the biomarker and the availability of biological samples
• The increasing use of large panels for comprehensive genomic profiling raises issues on data interpretation that require a multidisciplinary approach
• Monitoring the molecular evolution of the disease might allow the identification of resistance mechanisms and the development of more effective therapeutic strategies
• The identification of germline variants requires the activation of genetic counselling programs for patients and their families

Download the programme

Accreditation

The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

• Fabrice André, France
• Nicola Normanno, Italy